Skip to main navigation Skip to search Skip to main content

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe

  • Florence Broussais*
  • , Elise Pennings
  • , Natacha Bolanos
  • , Lorna Warwick
  • , Robin Doeswijk
  • , Gauthier Quinonez
  • , Andrii Lebeda
  • , Maria Gomes da Silva
  • , Sirpa Leppä
  • , Georg Lenz
  • , Anne-S. golène Cottereau
  • , Christopher Fox
  • , Armando Lopez-Guillermo
  • , Timothy Illidge
  • , Wojciech Jurczak
  • , Hans Eich
  • , Igor Aurer
  • , Marek Trneny
  • , Andy Andreas Rosenwald
  • , Andrew Davies
  • Ben Zwezerijnen, Jean-Philippe Jais, Martin Dreyling, Umberto Vitolo, Hervé Tilly, Catherine Thieblemont, Marie Jose Kersten
*Corresponding author for this work
  • Institut Carnot CALYM
  • Amsterdam UMC - University of Amsterdam
  • Lymphoma Coalition
  • European Hematology Association
  • Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.
  • University of Helsinki
  • University of Münster
  • Université Paris Cité
  • University of Nottingham
  • Hospital Clinic de Barcelona
  • University of Manchester
  • Maria Sklodowska-Curie Institute of Oncology
  • University of Zagreb
  • Charles University
  • University of Würzburg
  • University Hospital Southampton NHS Foundation Trust
  • Ludwig Maximilian University of Munich
  • IRCCS Fondazione del Piemonte per l'Oncologia - Candiolo (TO)
  • Centre Georges-François Leclerc

Research output: Contribution to journalComment/Letter to the editorAcademic

37 Downloads (Pure)
Original languageEnglish
Article numbere70204
JournalHemaSphere
Volume9
Issue number9
DOIs
Publication statusPublished - 1 Sept 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this